Annual SG&A
$3.56 M
-$383.20 K-9.72%
01 December 2023
Summary:
Creative Medical Technology Holdings annual selling, general & administrative expenses is currently $3.56 million, with the most recent change of -$383.20 thousand (-9.72%) on 01 December 2023. During the last 3 years, it has risen by +$2.40 million (+206.42%). CELZ annual SG&A is now -9.72% below its all-time high of $3.94 million, reached on 31 December 2022.CELZ Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$498.60 K
-$177.50 K-26.25%
01 September 2024
Summary:
Creative Medical Technology Holdings quarterly selling, general & administrative expenses is currently $498.60 thousand, with the most recent change of -$177.50 thousand (-26.25%) on 01 September 2024. Over the past year, it has dropped by -$900.10 thousand (-64.35%). CELZ quarterly SG&A is now -65.08% below its all-time high of $1.43 million, reached on 01 December 2021.CELZ Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$243.67 M
-$5.32 M-2.23%
01 September 2024
Summary:
Creative Medical Technology Holdings TTM selling, general & administrative expenses is currently -$243.67 million, with the most recent change of -$5.32 million (-2.23%) on 01 September 2024. Over the past year, it has dropped by -$247.23 million (-6944.39%). CELZ TTM SG&A is now -204840.20% below its all-time high of $4.47 million, reached on 30 September 2022.CELZ TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CELZ Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -64.3% | -6944.4% |
| 3 y3 years | +206.4% | -65.1% | -8320.0% |
| 5 y5 years | +191.1% | +60.3% | -10000.0% |
CELZ Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.7% | +206.4% | -65.1% | at low | -58.8% | at low |
| 5 y | 5 years | -9.7% | +206.4% | -65.1% | +132.0% | -197.9% | at low |
| alltime | all time | -9.7% | >+9999.0% | -65.1% | >+9999.0% | <-9999.0% | at low |
Creative Medical Technology Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $498.60 K(-26.3%) | $3.24 M(-1.0%) |
| June 2024 | - | $676.10 K(+0.7%) | $3.28 M(-5.3%) |
| Mar 2024 | - | $671.50 K(-52.0%) | $3.46 M(-2.8%) |
| Dec 2023 | $3.56 M(-9.7%) | $1.40 M(+163.4%) | $3.56 M(+16.3%) |
| Sept 2023 | - | $531.00 K(-38.2%) | $3.06 M(-8.2%) |
| June 2023 | - | $859.50 K(+11.5%) | $3.34 M(-6.9%) |
| Mar 2023 | - | $771.00 K(-14.3%) | $3.58 M(-9.1%) |
| Dec 2022 | $3.94 M(+33.0%) | $899.60 K(+11.7%) | $3.94 M(-11.8%) |
| Sept 2022 | - | $805.50 K(-27.3%) | $4.47 M(+1.1%) |
| June 2022 | - | $1.11 M(-1.9%) | $4.42 M(+16.0%) |
| Mar 2022 | - | $1.13 M(-20.9%) | $3.81 M(+28.6%) |
| Dec 2021 | $2.96 M(+155.1%) | - | - |
| Dec 2021 | - | $1.43 M(+88.6%) | $2.96 M(+60.0%) |
| Sept 2021 | - | $757.20 K(+52.0%) | $1.85 M(+34.2%) |
| June 2021 | - | $498.30 K(+77.4%) | $1.38 M(+25.8%) |
| Mar 2021 | - | $280.90 K(-11.1%) | $1.10 M(-5.6%) |
| Dec 2020 | $1.16 M(-5.0%) | $315.80 K(+10.8%) | $1.16 M(+0.4%) |
| Sept 2020 | - | $285.10 K(+32.7%) | $1.16 M(-2.7%) |
| June 2020 | - | $214.90 K(-37.9%) | $1.19 M(-7.6%) |
| Mar 2020 | - | $346.20 K(+11.3%) | $1.29 M(+5.2%) |
| Dec 2019 | $1.22 M(+16.4%) | $311.00 K(-2.1%) | $1.22 M(+4.6%) |
| Sept 2019 | - | $317.60 K(+1.6%) | $1.17 M(+3.1%) |
| June 2019 | - | $312.60 K(+10.9%) | $1.13 M(+0.4%) |
| Mar 2019 | - | $282.00 K(+9.6%) | $1.13 M(+7.5%) |
| Dec 2018 | $1.05 M(+16.9%) | $257.30 K(-9.0%) | $1.05 M(+11.4%) |
| Sept 2018 | - | $282.70 K(-8.1%) | $943.30 K(+9.4%) |
| June 2018 | - | $307.60 K(+51.6%) | $862.60 K(-6.5%) |
| Mar 2018 | - | $202.90 K(+35.2%) | $923.00 K(+2.7%) |
| Dec 2017 | $898.50 K(+35.1%) | $150.10 K(-25.7%) | $898.50 K(-2.3%) |
| Sept 2017 | - | $202.00 K(-45.1%) | $919.90 K(+4.2%) |
| June 2017 | - | $368.00 K(+106.3%) | $882.60 K(+25.7%) |
| Mar 2017 | - | $178.40 K(+4.0%) | $702.20 K(+5.6%) |
| Dec 2016 | $665.00 K | $171.50 K(+4.1%) | $665.00 K(+33.1%) |
| Sept 2016 | - | $164.70 K(-12.2%) | $499.80 K(+47.5%) |
| June 2016 | - | $187.60 K(+32.9%) | $338.80 K(+118.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $141.20 K(+2141.3%) | $155.00 K(+645.2%) |
| Dec 2015 | $20.80 K(+7.2%) | $6300.00(+70.3%) | $20.80 K(+11.2%) |
| Sept 2015 | - | $3700.00(-2.6%) | $18.70 K(+0.5%) |
| June 2015 | - | $3800.00(-45.7%) | $18.60 K(+1.1%) |
| Mar 2015 | - | $7000.00(+66.7%) | $18.40 K(-5.2%) |
| Dec 2014 | $19.40 K(-3.5%) | $4200.00(+16.7%) | $19.40 K(+0.5%) |
| Sept 2014 | - | $3600.00(0.0%) | $19.30 K(0.0%) |
| June 2014 | - | $3600.00(-55.0%) | $19.30 K(-2.0%) |
| Mar 2014 | - | $8000.00(+95.1%) | $19.70 K(-2.5%) |
| Dec 2013 | $20.10 K(0.0%) | $4100.00(+13.9%) | $20.20 K(-1.9%) |
| Sept 2013 | - | $3600.00(-10.0%) | $20.60 K(-2.4%) |
| June 2013 | - | $4000.00(-52.9%) | $21.10 K(+1.4%) |
| Mar 2013 | - | $8500.00(+88.9%) | $20.80 K(+3.5%) |
| Dec 2012 | $20.10 K(+1.5%) | $4500.00(+9.8%) | $20.10 K(-5.2%) |
| Sept 2012 | - | $4100.00(+10.8%) | $21.20 K(+2.9%) |
| June 2012 | - | $3700.00(-52.6%) | $20.60 K(+1.5%) |
| Mar 2012 | - | $7800.00(+39.3%) | $20.30 K(+2.5%) |
| Dec 2011 | $19.80 K(+38.5%) | $5600.00(+60.0%) | $19.80 K(+15.1%) |
| Sept 2011 | - | $3500.00(+2.9%) | $17.20 K(+4.2%) |
| June 2011 | - | $3400.00(-53.4%) | $16.50 K(+15.4%) |
| Mar 2011 | - | $7300.00(+143.3%) | $14.30 K(0.0%) |
| Dec 2010 | $14.30 K(-53.3%) | $3000.00(+7.1%) | $14.30 K(-30.2%) |
| Sept 2010 | - | $2800.00(+133.3%) | $20.50 K(+1.0%) |
| June 2010 | - | $1200.00(-83.6%) | $20.30 K(-28.0%) |
| Mar 2010 | - | $7300.00(-20.7%) | $28.20 K(-7.8%) |
| Dec 2009 | $30.60 K(-42.8%) | $9200.00(+253.8%) | $30.60 K(-8.1%) |
| Sept 2009 | - | $2600.00(-71.4%) | $33.30 K(-40.1%) |
| June 2009 | - | $9100.00(-6.2%) | $55.60 K(-4.0%) |
| Mar 2009 | - | $9700.00(-18.5%) | $57.90 K(+8.4%) |
| Dec 2008 | $53.50 K(+293.4%) | $11.90 K(-52.2%) | $53.40 K(+6.8%) |
| Sept 2008 | - | $24.90 K(+118.4%) | $50.00 K(+70.1%) |
| June 2008 | - | $11.40 K(+119.2%) | $29.40 K(+63.3%) |
| Mar 2008 | - | $5200.00(-38.8%) | $18.00 K(+40.6%) |
| Dec 2007 | $13.60 K(+871.4%) | $8500.00(+97.7%) | $12.80 K(+197.7%) |
| Sept 2007 | - | $4300.00 | $4300.00 |
| Dec 2006 | $1400.00 | - | - |
FAQ
- What is Creative Medical Technology Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly SG&A year-on-year change?
- What is Creative Medical Technology Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings TTM SG&A year-on-year change?
What is Creative Medical Technology Holdings annual selling, general & administrative expenses?
The current annual SG&A of CELZ is $3.56 M
What is the all time high annual SG&A for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high annual selling, general & administrative expenses is $3.94 M
What is Creative Medical Technology Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of CELZ is $498.60 K
What is the all time high quarterly SG&A for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high quarterly selling, general & administrative expenses is $1.43 M
What is Creative Medical Technology Holdings quarterly SG&A year-on-year change?
Over the past year, CELZ quarterly selling, general & administrative expenses has changed by -$900.10 K (-64.35%)
What is Creative Medical Technology Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of CELZ is -$243.67 M
What is the all time high TTM SG&A for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high TTM selling, general & administrative expenses is $4.47 M
What is Creative Medical Technology Holdings TTM SG&A year-on-year change?
Over the past year, CELZ TTM selling, general & administrative expenses has changed by -$247.23 M (-6944.39%)